Decoding Apelin: Its Role in Metabolic Programming, Fetal Growth, and Gestational Complications

• Published in: Children (Basel) 2024-10, Vol.11 (10), p.1270
• Main Authors: Loukas, Nikolaos, Vrachnis, Dionysios, Antonakopoulos, Nikolaos, Stavros, Sofoklis, Machairiotis, Nikolaos, Fotiou, Alexandros, Christodoulaki, Chryssi, Lolos, Markos, Maroudias, Georgios, Potiris, Anastasios, Drakakis, Petros, Vrachnis, Nikolaos
• Format: Article
• Language: English
• Subjects: Adipocytes; Amino acids; amniotic fluid; Angiogenesis; apelin; Blood pressure; Body fat; Cell growth; Complications and side effects; Dextrose; Fatty acids; fetal development; fetal growth restriction; fetal metabolic programming; Fetus; Gestational diabetes; Glucose; Glucose metabolism; Growth; Homeostasis; Inflammation; Insulin resistance; Kinases; Metabolism; Obesity; Oxidation; Oxidative stress; Peptides; Physiology; Plasma; Preeclampsia; Pregnancy; Proteins; Review; small for gestational age (SGA); Thermogenesis; Type 2 diabetes
• ISSN: 2227-9067; 2227-9067
• DOI: 10.3390/children11101270

Placental insufficiency and gestational diabetes, which are both serious pregnancy complications, are linked to altered fetal growth, whether restricted or excessive, and result in metabolic dysfunction, hypoxic/oxidative injury, and adverse perinatal outcomes. Although much research has been carried out in this field, the underlying pathogenetic mechanisms have not as yet been fully elucidated. Particularly because of the role it plays in cardiovascular performance, glucose metabolism, inflammation, and oxidative stress, the adipokine apelin was recently shown to be a potential regulator of fetal growth and metabolic programming. This review investigated the numerous biological actions of apelin in utero and aimed to shed more light on its role in fetal growth and metabolic programming. The expression of the apelinergic system in a number of tissues indicates its involvement in many physiological mechanisms, including angiogenesis, cell proliferation, energy metabolism, inflammation, and oxidative stress. Moreover, it appears that apelin has a major function in disorders such as diabetes mellitus, fetal growth abnormalities, fetal hypoxia, and preeclampsia. We herein describe in detail the regulatory effects exerted by the adipokine apelin on fetal growth and metabolic programming while stressing the necessity for additional research into the therapeutic potential of apelin and its mechanisms of action in pregnancy-related disorders.